The Brest cancer screening test is a medical screening of as asymptomatic, which is carried out to detect cancer in its early stage and ensure the medical treatment effectively. The breast cancer screening test is offered for women aged between 50-70 years as they are likely to porn to the diseases. Breast cancer has been growing significantly and is one of the most common cancers among women globally. According to WHO, Cancer is the second leading cause of death globally and responsible for an estimate of 9.6 Million death in 2018. And, Approximately 70% of death has caused by cancer which has occurred in low and middle-income countries.This growth is primarily driven by Growing Incidence of Breast Cancer and Related Disease Death, Increasing Awareness of Early Detection of Breast Cancer, Government Initiatives and National Level Program Organized and Growth in the Number of Private Diagnostic Centers.
Globally, a noticeable market trend is evident Technology Advancements in Breast Cancer Screening and Artificial Intelligence
. Major Players, such as A & G Pharmacuetical Inc. (United States), Agendia BV (Netherlands), Myriad Genetics (United States), Metabolomic Technologies Inc. (Canada), Roche Holding AG (Switzerland), Biocrates Life Science AG (Austria), Hologic (United States), GE Healthcare (United States), Siemen Healthineers (Germany) and Philips Healthcare Informatics (United States) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.
Key Developments in the Market:
In November 2017, Hologic, Inc. has provided all mammography systems for the Dutch Breast Cancer Screening Program in partnership with Tromp Medical.
In November 2018, Sabre, the global leader in consumer safety and law enforcement products has raised more than USD 1.7 Million for National Breast Cancer Foundation. A mission-driven organization and partners of NBCF, SABRE empowered people to enjoy their lifestyle. The proceeds and successful implementation has recently helped launch the National Mammography Program which has provided almost 300,000 screening and diagnostic services to women in need.
According to WHO – “ Breast cancer is the most frequent cancer among women, impacting 2.1 million women each year, and also causes the greatest number of cancer-related deaths among women. In 2018, it is estimated that 627,000 women died from breast cancer – that is approximately 15% of all cancer deaths among women.” The screening consist of testing women to identify cancers before any symptoms appear. Various methods have been evaluated as breast cancer screening tools, including mammography, clinical breast exam and breast self-exam.
- Growing Incidence of Breast Cancer and Related Disease Death
- Increasing Awareness of Early Detection of Breast Cancer
- Government Initiatives and National Level Program Organized
- Growth in the Number of Private Diagnostic Centers
- Technology Advancements in Breast Cancer Screening and Artificial Intelligence
- Personalized Approach to Breast Screening
- Stringent Rules and Regulations For Breast Cancer Screening
- High Cost Involved in Breast Cancer Screening Affecting Their Rate of Adoption in Emerging Market
Improving Healthcare Infrastructure in Emerging Market and Miniaturization and Technologies Advancements
Hospital Budget Cuts A Key Challenge to Market Players and Lack of Skilled and Experienced Personnels
AdvanceMarketAnalytics follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.
Customization of the Report:
AMA Research & Media features not only specific market forecasts, but also include significant value-added commentary on:
Technological Trends and Innovations
Regulatory Trends & Policies
Market Maturity Indicators
Market Share Movements
Growth Drivers and Constraints
New Entrants into the Market & Entry/Exit Barriers
Supporting Company Financial and Cash Flow Planning
Open Up New Markets
To Seize Powerful Market Opportunities
Key Decision in Planning and to Further Expand Market Share
Identify Key Business Segments, Market Proposition & Gap Analysis